Study guide
7.4 Inhaled Medication Delivery Technique and Patient Education
Certified Pulmonary Function Technologist CPFT
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Overview & NBRC Certification Requirements
1.1 NBRC PFT Exam Logistics, Format, and Scoring Criteria 1.2 Scope of Practice, Candidate Admission Pathways, and Credential Maintenance 1.3 Professional Standards, Ethics, and Patient Safety in Diagnostic Testing
2 Chapter 2: Spirometry Equipment & Sensors
2.1 Volume-Displacement Spirometers: Water-Seal, Rolling-Seal, Bellows 2.2 Flow-Sensing Pneumotachometers: Fleisch, Lilly, Vortex, Turbine, Pitot Tube, Ultrasonic 2.3 Calibration Standards & 3-Liter Syringe Quality Control Verification
3 Chapter 3: Body Plethysmography & Hardware
3.1 Body Plethysmograph Principles: Pressure, Volume, and Variable-Pressure-Constant-Volume Design 3.2 Plethysmograph Calibration, Pressure Transducers, and Shutter Mechanics 3.3 Quality Control, Isothermal Corrections, and Leak Detection in Plethysmography
4 Chapter 4: Gas Analyzers, Environmental Sensors, & Infection Control
4.1 Rapid and Multi-Gas Analyzers: Infrared, Zirconium, Mass Spec, Electrochemical, Thermal Conductivity 4.2 Environmental Sensors, Barometric Pressure, Temperature, and BTPS Correction Factors 4.3 Infection Control, Equipment Decontamination, Disposable Filters, and Spaulding Classification 4.4 Monitors: Pulse Oximeters, Blood Pressure Devices, and ECG Equipment 4.5 Gas Delivery Systems, Valves, Absorbers, and Aerosol / Inhaler Devices
5 Chapter 5: Spirometry Protocols & ATS/ERS Criteria
5.1 Forced Vital Capacity (FVC) and Slow Vital Capacity (SVC) Testing Protocols 5.2 ATS/ERS Spirometry Acceptability, Repeatability, and Usability Criteria 5.3 Peak Expiratory Flow Rate (PEFR), Maximum Voluntary Ventilation (MVV), and Flow-Volume Loops
6 Chapter 6: Lung Volume Determination Protocols
6.1 Open-Circuit Nitrogen Washout Method: Principles, Equipment, and Calculation 6.2 Closed-Circuit Helium Dilution Method: Principles, Equipment, and Calculation 6.3 Thoracic Gas Volume (TGV/FRCpleth) and Comparison of Lung Volume Methods
7 Chapter 7: Diffusing Capacity & Bronchial Challenge Testing
7.1 Single-Breath Carbon Monoxide Diffusing Capacity (DLCO) Testing Protocol 7.2 DLCO Calculations, Hemoglobin/COHb/Altitude Corrections, and VA 7.3 Bronchial Provocation Testing: Methacholine Challenge, Exercise-Induced Bronchospasm, and EIB Protocols 7.4 Inhaled Medication Delivery Technique and Patient Education
8 Chapter 8: Cardiopulmonary Exercise & ABG Testing
8.1 Cardiopulmonary Exercise Testing (CPET) Protocols, VO2max, and Anaerobic Threshold 8.2 Six-Minute Walk Test (6MWT) Protocol, Desaturation Monitoring, and O2 Titration 8.3 Arterial Blood Gas (ABG) Sampling, Allen Test, Analyzer Maintenance, and Quality Control 8.4 Pulse Oximetry and Oxygen Assessment: Principles, Limitations, and Titration Data 8.5 CO-Oximetry / Hemoximetry: Measurement, Dyshemoglobins, and Clinical Implications 8.6 Exercise Monitoring Data: Blood Pressure Response and ECG Rhythm Analysis
9 Chapter 9: Reference Values & PFT Calculations
9.1 Predicted Value Equations, Reference Populations, and GLI 2012 / ATS/ERS 2022 Standards 9.2 BTPS, STPD, and ATPS Conversion Formulas and Calculations 9.3 Gas Exchange Formulas, Alveolar Air Equation, and Mechanical Calculations
10 Chapter 10: Pattern Recognition & Clinical PFT Interpretation
10.1 Obstructive Ventilatory Defects: Asthma, COPD, Emphysema, Chronic Bronchitis, Bronchiectasis 10.2 Restrictive Ventilatory Defects: Parenchymal, Chest Wall, and Neuromuscular Disorders 10.3 Mixed Ventilatory Defects, Isolated Diffusion Defects, and Reversibility Protocols
11 Chapter 11: Artifact Recognition & Quality Assurance
11.1 Spirometry Artifacts: Hesitation, Coughing, Early Termination, Glottic Closure, Leak 11.2 Lung Volume and DLCO Artifacts: Panting Frequency, Shutter Leaks, Breath-Hold Failure 11.3 Quality Control Charts, Westgard Rules, and Laboratory Quality Assurance
12 Chapter 12: Documentation, Compliance, & Emergency Safety
12.1 PFT Reporting Standards, Tabular Formats, and Interpretation Graphics 12.2 CPT Billing Codes, ICD-10 Coding, HIPAA Privacy, and EHR Compliance 12.3 Emergency Preparedness, Contraindications, and Patient Safety Management in PFT Lab
13 Chapter 13: Specialized Procedures, Home Testing & Longitudinal Data
13.1 Respiratory Muscle Strength: MIP, MEP, SNIP, and Cough Peak Flow 13.2 Sputum Sample Collection: Spontaneous and Induced Specimens 13.3 Home Testing Instruction: Home Spirometry, Peak Flow Diaries, and Home Oximetry 13.4 Pediatric Pulmonary Function Testing and Upright Versus Supine Spirometry 13.5 Serial Pulmonary Function Testing, Clinical History, Demographics, and Laboratory Quality Management
7.4 Inhaled Medication Delivery Technique and Patient Education
Key Takeaways Explain This Topic AI
Inhaled medication delivery appears as task 3 under all three Domain II verbs, so the exam tests device selection, correct administration, and how to judge whether the dose actually reached the lung.
Pressurized metered dose inhalers require a slow deep inspiration of about 30 L/min with a 10-second breath hold, while dry powder inhalers require a fast forceful inspiration and must never be exhaled into.
A valved holding chamber removes the need for hand-breath coordination and reduces oropharyngeal deposition, which is why bronchodilator-response protocols specify four separate actuations through a spacer.
Patient education is its own scored task (Domain II item 11) covering medication delivery technique, asthma action plans, and air-travel oxygen planning.
Commercial aircraft cabins are pressurized to a maximum equivalent altitude of 8,000 feet, which is why a hypoxic altitude simulation test uses an inspired oxygen fraction of about 15%.
Last updated: August 2026
7.4 Inhaled Medication Delivery Technique and Patient Education
Two Domain II tasks are almost always underestimated by candidates: item 3, inhaled medication delivery and item 11, patient education . Both are examined under all three task verbs — select , perform , and evaluate validity — which means roughly a dozen scored items can touch them. They matter clinically for the same reason: a bronchodilator-response study is only as valid as the drug that actually reached the airway, and a patient who leaves the laboratory unable to use their inhaler correctly has received a diagnosis without a treatment.
Device Classes and the Inspiratory Maneuver Each Requires
The single most testable concept is that different devices require opposite breathing patterns . Coaching a patient into the wrong maneuver wastes the dose.
Device Required Inspiration Breath Hold Key Failure Mode
Pressurized MDI (pMDI) Slow and deep , about 30 L/min over 4–5 s 10 seconds Actuation–inhalation mismatch; cold-Freon reflex
pMDI + valved holding chamber Slow and deep, or tidal breathing in small children 10 s (or 5–6 tidal breaths) Electrostatic charge on a new plastic chamber
Soft mist inhaler Slow and deep 10 seconds Failure to prime/twist the base fully
Dry powder inhaler (DPI) Fast and forceful from the start 10 seconds Inadequate inspiratory flow; exhaling into the device
Small-volume jet nebulizer Normal tidal breathing with occasional deep breaths Not required Fill volume, driving flow, and tapping the reservoir
pMDI physics. A pressurized canister fires a plume that is initially fast-moving; a slow inhalation lets the propellant evaporate and the particles decelerate so they reach the lower airway rather than impacting on the posterior pharynx. Firing during a fast inhalation deposits more drug in the throat.
DPI physics. The drug is a micronized powder blended with a carrier such as lactose. Only turbulent energy generated by the patient's own fast inspiration disaggregates the powder into respirable particles. A patient generating inadequate inspiratory flow — severe obstruction, muscle weakness, young children — receives little drug from a DPI regardless of technique. Exhaling into a DPI adds humidity that clumps the powder and can blow the metered dose away entirely.
Correct pMDI Technique, Step by Step
Remove the cap and inspect the actuator orifice for drug residue.
Shake for 5 seconds. Suspension formulations separate.
Prime if new or unused for the interval stated in the package insert.
Exhale to functional residual capacity — not a forced exhalation to residual volume.
Place the mouthpiece between the teeth with lips sealed (or use a spacer).
Begin a slow inspiration, then actuate once within the first quarter of the breath.
Continue inhaling slowly to total lung capacity.
Hold the breath 10 seconds , then exhale slowly.
Wait 30–60 seconds between actuations.
Rinse and spit after inhaled corticosteroids to prevent oropharyngeal candidiasis.
The Valved Holding Chamber
A spacer with a one-way valve accomplishes three things: it removes the need for hand-breath coordination, it allows propellant to evaporate so the particle size distribution shifts into the respirable range, and it traps large particles that would otherwise deposit in the oropharynx. That is precisely why the standard bronchodilator-response protocol calls for four separate actuations, each individually inhaled through a spacer with a 30-second interval , rather than four rapid puffs. New plastic chambers carry an electrostatic charge that attracts drug to the wall; wash with dilute detergent and air dry without rinsing or wiping to leave an antistatic film.
Evaluating Whether the Dose Was Actually Delivered
Domain II.C asks the technologist to evaluate the validity of inhaled medication delivery. Concretely:
Watch the maneuver. Cheeks ballooning, a plume escaping from the lips, a whistling spacer flow-signal (many chambers whistle when inspiration is too fast), or a patient who exhales immediately after actuation all indicate a failed dose.
Check the count. Dose counters exist for a reason; a canister that floats is not a valid emptiness test.
Reconcile with the physiology. A post-bronchodilator study showing a fall in FEV 1 _1 1 raises three possibilities, in order: submaximal post-dose effort, genuine paradoxical bronchoconstriction (rare, usually to a propellant or preservative), or failed delivery.
Repeat with a different route. If technique cannot be corrected, deliver the bronchodilator by jet nebulizer and document the change; the report must state the drug, dose, device, and time interval before the post-dose maneuver.
Patient Education: The Three Topics the Outline Names
The DCO gives three examples for item 11 — medication delivery, travel, and asthma — and each is a distinct teaching task.
1. Medication Delivery Education
Teach-back is the standard: demonstrate, then have the patient demonstrate to you. Roughly two-thirds of patients make at least one critical error with a pMDI, and the most common ones are failure to shake, failure to exhale first, actuating after inhalation has begun in earnest, and no breath hold. Document which device the patient uses at home and any error corrected.
2. Travel Education and Air-Travel Oxygen
Commercial aircraft cabins are pressurized to a maximum equivalent altitude of 8,000 feet , where barometric pressure falls to roughly 565 mmHg and inspired PO 2 _2 2 falls accordingly. A patient with borderline resting oxygenation at sea level can become significantly hypoxemic in flight.
Screening rule of thumb: a resting sea-level SpO 2 _2 2 below 92% (or PaO 2 _2 2 below 70 mmHg) generally warrants formal assessment before flying.
Hypoxic altitude simulation test (HAST): the patient breathes a hypoxic mixture of about 15% oxygen (nitrogen balance), simulating 8,000 feet, while SpO 2 _2 2 and often arterial blood gases are monitored. In-flight supplemental oxygen is typically recommended if PaO 2 _2 2 falls below 50–55 mmHg .
Practical counseling: portable oxygen concentrators must be airline-approved and carried with sufficient battery life, airlines require advance notice, and patients should carry medications in the cabin rather than in checked baggage.
3. Asthma Education and the Action Plan
A written asthma action plan is built around the patient's personal best peak expiratory flow , established over two to three weeks of good control:
Green zone (80–100% of personal best): good control; continue maintenance therapy.
Yellow zone (50–80%): worsening; use quick-relief medication as prescribed and follow the plan's step-up instructions.
Red zone (below 50%): medical alert; take rescue medication and seek immediate care.
Reinforce trigger avoidance, the distinction between controller and reliever inhalers (a patient who reaches for a corticosteroid during an attack has a dangerous misunderstanding), correct peak-flow-meter technique with the marker reset to zero and the best of three efforts recorded, and the fact that a peak flow meter measures large-airway flow and can look reassuring while small-airway obstruction worsens.